HTA Council Recommendation (as of 11 June 2026) As a final recommendation, the HTA Council recommends the government financing of the following: for use in diagnostic magnetic resonance imaging (MRI) in adults and children. Relevant Information Evidence and Relevant Documents Assessment History Back to Assessments Page
Multiple Micronutrient Supplement [film-coated tablet] for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women
HTA Council Recommendation (as of 13 February 2026) As final recommendation, the HTA Council recommends the government financing of Multiple Micronutrient Supplement [film-coated tablet] for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women. Relevant Information Evidence and Relevant Documents Assessment History Back to continue reading : Multiple Micronutrient Supplement [film-coated tablet] for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women
Mesalazine [1g, 2g prolonged-release granules; 1g suppository] for management of ulcerative colitis and ulcerative proctitis
HTA Council Recommendation (as of 10 October 2023) As final recommendation, the HTA Council recommends the government financing of mesalazine [1g, 2g prolonged-release granules; 1g suppository] for management of ulcerative colitis and ulcerative proctitis through its inclusion in the Philippine National Formulary (PNF). Relevant Information Evidence and Relevant Documents Assessment History Back to Assessments Page
Insuline glargine [100IU/mL 3mL vial (SC)] for treatment of type 1 and type 2 diabetes mellitus
HTA Council Recommendation (as of 16 September 2023) As final recommendation, the HTA Council recommends the inclusion of insulin glargine [100IU/mL 3mL vial (SC)] for treatment of type 1 and type 2 diabetes mellitus in the Philippine National Formulary (PNF). Relevant Information Evidence and Relevant Documents Assessment History Back to Assessments Page
Deferasirox [90mg and 180mg Film Coated Tablet] for management of chronic iron overload due to repetitive blood transfusions in patients 2 years old and above
HTA Council Recommendation (as of 12 January 2023) As final recommendation, the HTA Council recommends the inclusion of deferasirox [90mg and 180mg film coated tablet] for management of chronic iron overload due to repetitive blood transfusions in patients 2 years old and above in the Philippine National Formulary (PNF). Relevant Information Evidence and Relevant Documents continue reading : Deferasirox [90mg and 180mg Film Coated Tablet] for management of chronic iron overload due to repetitive blood transfusions in patients 2 years old and above